| Avastatin - Drugs.com Avastatin is a medicine available in a number of countries worldwide. A list of US medications equivalent to Avastatin is available on the Drugs.com website. Read More |
| Bevacizumab - Wikipedia, the free encyclopedia Bevacizumab (trade name Avastin, Genentech / Roche) is a drug that slows angiogenesis, the growth of new blood vessels. It is licenced to treat various cancers ... Read More |
| Avastin® (bevacizumab) Treatment for mCRC, NSCLC, GBM and mRCC ... Learn about Avastin (bevacizumab) for the treatment of metastatic colorectal cancer (colon cancer), non–small cell lung cancer, glioblastoma & metastatic kidney cancer. Read More |
| Avastin (Bevacizumab) Drug Information: Description, User Reviews ... Learn about the prescription medication Avastin (Bevacizumab), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Cancer Surgery - Cancer Therapy, Cancer Treatment, Cancer Patients ... Avastatin® is now being studied for the treatment of many different cancers. Patients with newly diagnosed metastatic colon cancer who received Avastatin® along with a ... Read More |
| Avastin (bevacizumab) medical facts from Drugs.com Physician reviewed Avastin patient information - includes Avastin description, dosage and directions. Read More |
| AVASTATIN Trademark Details - Healthcare News, Blogs, Suppliers ... Trademark details. Avastatin® is a registered trademark used for Pharmaceutical Preparations and Substances For the Treatment of Infectious Diseases, Pain ... Read More |
| Bevacizumab (Avastatin) - Mesothelioma Journal Articles Pemetrexed, a multitargeted antifolate agent, has shown clear activity in several tumors, including mesothelioma and NSCLC. In a phase III trial, second-line ... Read More |
| Comparison of AMD Treatments Trials (CATT): Lucentis – Avastin ... Comparison of AMD Treatments Trials (CATT): Lucentis — Avastin Trial. The National Eye Institute (NEI) of the National Institutes of Health (NIH) announces ... Read More |
| Genentech: Medicines: Avastin Avastin is the first U.S. Food and Drug Administration (FDA) approved therapy designed to inhibit angiogenesis, the process by which new blood vessels develop and ... Read More |
